New study reveals hallucinogenic drug psilocybin reduces cancer patients' distress

A new study conducted by NYU Langone Medical Center researchers has revealed that a single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news